Trials / Withdrawn
WithdrawnNCT02245776
Stem Cell Therapy in Incurable Neurological Disorders
Autologous Bone Marrow Mononuclear Cell Therapy for Incurable Neurological Disorders
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Neurogen Brain and Spine Institute · Academic / Other
- Sex
- All
- Age
- 6 Months – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study was to analyze the benefit of autologous mononuclear cell therapy in incurable neurological disorders.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Stem Cell | Intrathecal autologous bone marrow mononuclear cell transplantation |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2018-06-01
- Completion
- 2018-12-01
- First posted
- 2014-09-22
- Last updated
- 2018-10-25
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT02245776. Inclusion in this directory is not an endorsement.